Literature DB >> 9736050

Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein.

D H Smith1, M Nakamura, T K McIntosh, J Wang, A Rodríguez, X H Chen, R Raghupathi, K E Saatman, J Clemens, M L Schmidt, V M Lee, J Q Trojanowski.   

Abstract

Although brain trauma is a risk factor for Alzheimer's disease, no experimental model has been generated to explore this relationship. We developed a model of brain trauma in transgenic mice that overexpress mutant human amyloid precursor protein (PDAPP) leading to the appearance of Alzheimer's disease-like beta-amyloid (Abeta) plaques beginning at 6 months of age. We induced cortical impact brain injury in the PDAPP animals and their wild-type littermates at 4 months of age, ie, before Abeta plaque formation, and evaluated changes in posttraumatic memory function, histopathology, and regional tissue levels of the Abeta peptides Abeta1-40 and Abeta1-42. We found that noninjured PDAPP mice had impaired memory function compared to noninjured wild-type littermates (P < 0.01) and that brain-injured PDAPP mice had more profound memory dysfunction than brain-injured wild-type littermates (P < 0.001). Although no augmentation of Abeta plaque formation was observed in brain-injured PDAPP mice, a substantial exacerbation of neuron death was found in the hippocampus (P < 0.001) in association with an acute threefold increase in Abeta1-40 and sevenfold increase in Abeta1-42 levels selectively in the hippocampus (P < 0.01). These data suggest a mechanistic link between brain trauma and Abeta levels and the death of neurons.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736050      PMCID: PMC1853010          DOI: 10.1016/s0002-9440(10)65643-x

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

Authors:  M C Irizarry; F Soriano; M McNamara; K J Page; D Schenk; D Games; B T Hyman
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

2.  Temporal and regional patterns of axonal damage following traumatic brain injury: a beta-amyloid precursor protein immunocytochemical study in rats.

Authors:  H M Bramlett; S Kraydieh; E J Green; W D Dietrich
Journal:  J Neuropathol Exp Neurol       Date:  1997-10       Impact factor: 3.685

3.  Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein.

Authors:  F Zhang; C Eckman; S Younkin; K K Hsiao; C Iadecola
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

4.  Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.

Authors:  K Johnson-Wood; M Lee; R Motter; K Hu; G Gordon; R Barbour; K Khan; M Gordon; H Tan; D Games; I Lieberburg; D Schenk; P Seubert; L McConlogue
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

5.  The occult aftermath of boxing.

Authors:  G W Roberts; D Allsop; C Bruton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-05       Impact factor: 10.154

6.  APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1.

Authors:  M C Irizarry; M McNamara; K Fedorchak; K Hsiao; B T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  1997-09       Impact factor: 3.685

7.  Association of apolipoprotein E polymorphism with outcome after head injury.

Authors:  G M Teasdale; J A Nicoll; G Murray; M Fiddes
Journal:  Lancet       Date:  1997-10-11       Impact factor: 79.321

8.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

9.  Molecular features of hypothalamic plaques in Alzheimer's disease.

Authors:  D G Standaert; V M Lee; B D Greenberg; D E Lowery; J Q Trojanowski
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

10.  Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group.

Authors:  J A Mortimer; C M van Duijn; V Chandra; L Fratiglioni; A B Graves; A Heyman; A F Jorm; E Kokmen; K Kondo; W A Rocca
Journal:  Int J Epidemiol       Date:  1991       Impact factor: 7.196

View more
  47 in total

1.  Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury.

Authors:  David L Brody; David M Holtzman
Journal:  Exp Neurol       Date:  2005-11-23       Impact factor: 5.330

2.  Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities.

Authors:  Hien T Tran; Frank M LaFerla; David M Holtzman; David L Brody
Journal:  J Neurosci       Date:  2011-06-29       Impact factor: 6.167

3.  Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice.

Authors:  Anders Hånell; Fredrik Clausen; Maria Björk; Kristine Jansson; Ola Philipson; Lars N G Nilsson; Lars Hillered; Paul H Weinreb; Daniel Lee; Tracy K McIntosh; David A Gimbel; Stephen M Strittmatter; Niklas Marklund
Journal:  J Neurotrauma       Date:  2010-07       Impact factor: 5.269

4.  Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.

Authors:  M D Kane; W J Lipinski; M J Callahan; F Bian; R A Durham; R D Schwarz; A E Roher; L C Walker
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

Review 5.  The pathophysiology of concussions in youth.

Authors:  Daniel W Shrey; Grace S Griesbach; Christopher C Giza
Journal:  Phys Med Rehabil Clin N Am       Date:  2011-09-25       Impact factor: 1.784

6.  Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury.

Authors:  Annika Olsson; Ludvig Csajbok; Martin Ost; Kina Höglund; Karin Nylén; Lars Rosengren; Bengt Nellgård; Kaj Blennow
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 7.  What can rodent models tell us about cognitive decline in Alzheimer's disease?

Authors:  Sabrina Davis; Serge Laroche
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

8.  Gene-environment interaction research and transgenic mouse models of Alzheimer's disease.

Authors:  L Chouliaras; A S R Sierksma; G Kenis; J Prickaerts; M A M Lemmens; I Brasnjevic; E L van Donkelaar; P Martinez-Martinez; M Losen; M H De Baets; N Kholod; F van Leeuwen; P R Hof; J van Os; H W M Steinbusch; D L A van den Hove; B P F Rutten
Journal:  Int J Alzheimers Dis       Date:  2010-10-05

9.  Cerebral blood flow changes after brain injury in human amyloid-beta knock-in mice.

Authors:  Eric E Abrahamson; Lesley M Foley; Steven T Dekosky; T Kevin Hitchens; Chien Ho; Patrick M Kochanek; Milos D Ikonomovic
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-27       Impact factor: 6.200

Review 10.  Active and passive immunotherapy for neurodegenerative disorders.

Authors:  David L Brody; David M Holtzman
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.